Fewer patients in the deferred stenting group had no - / slow-reflow ( @ -LSB- @ % -RSB- vs. @ -LSB- @ % -RSB- ; p = @ ) , no reflow ( @ -LSB- @ % -RSB- vs. @ -LSB- @ % -RSB- ; p = @ ) and intraprocedural thrombotic events ( @ -LSB- @ % -RSB- vs. @ -LSB- @ % -RSB- ; p = @ ) .